Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Can Use of Bismuth Subsalicylate in Clostridium Difficile Patients Decrease the Length of Stay and Time to Resolution of Symptoms

NCT03592082 is registered in ClinicalTrials.gov with Bassett Healthcare as lead sponsor.

NCT NCT03592082
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03592082 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Can Use of Bismuth Subsalicylate in Clostridium Difficile Patients Decrease the Length of Stay and Time to Resolution of Symptoms
Lead sponsor
Bassett Healthcare
Phase
Phase 4
Overall status
Withdrawn
Start date
March 1, 2018
Completion date
July 1, 2018
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

clostridium difficile infection